Mafenide Hydrochloride
CAS 138-37-4
Mafenide Hydrochloride (CAS 138-37-4) is a pharmaceutical compound with 4 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 19020.7 nM | 3 | - |
| - | AC50 | 2837.1000000000004 nM | 2 | - |
| - | IC50 | 33330 nM | 2 | - |
| - | Ki | 12585 nM | 2 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Mafenide Hydrochloride used for in pharmaceutical contexts?
Mafenide Hydrochloride (CAS 138-37-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Mafenide Hydrochloride?
No adverse-event association or SIDER side-effect rows are rendered for Mafenide Hydrochloride in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Mafenide Hydrochloride also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Mafenide HCl with EU status "permitted".
What clinical phase is Mafenide Hydrochloride in?
No phase 1-4 clinical development badge is rendered for Mafenide Hydrochloride because the matched compound identifier rows do not contain a max-phase value.